{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T08:48:29Z","timestamp":1791708509233,"version":"4.3.4"},"reference-count":24,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cancer Control"],"published-print":{"date-parts":[[2026,2,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Triple-negative breast cancer (TNBC) represents approximately 10-20% of all breast cancer cases and is frequently associated with\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      mutations. Numerous studies from Western populations have investigated the prevalence of germline\n                      <jats:italic toggle=\"yes\">BRCA<\/jats:italic>\n                      mutations in individuals with TNBC; however, the prevalence of\n                      <jats:italic toggle=\"yes\">BRCA1\/2<\/jats:italic>\n                      mutations in TNBC patients varies widely between countries and from study to study. Evidence from Asian populations, particularly Vietnamese patients, remains limited. In this study, we determined the prevalence of germline\n                      <jats:italic toggle=\"yes\">BRCA1\/2<\/jats:italic>\n                      mutations among unselected Vietnamese patients with TNBC and analyzed the clinicopathological features.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a single-center retrospective study of 68 women diagnosed with TNBC at the Vietnam National Cancer Hospital. Germline\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      \/\n                      <jats:italic toggle=\"yes\">2<\/jats:italic>\n                      testing was performed by next-generation sequencing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 19 Vietnamese patients (27.9%) had\n                      <jats:italic toggle=\"yes\">BRCA1\/2<\/jats:italic>\n                      mutations, with 14 (20.6%) in\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      and 5 (7.4%) in\n                      <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n                      . Three patients (4.4%) had variants of uncertain significance (2\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      mutations and 1\n                      <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n                      mutation). Thirteen distinct pathogenic or likely pathogenic variants (8\n                      <jats:italic toggle=\"yes\">BRCA1<\/jats:italic>\n                      and 5\n                      <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n                      ) were found. Among patients diagnosed at \u226460\u00a0years, the prevalence of\n                      <jats:italic toggle=\"yes\">BRCA1\/2<\/jats:italic>\n                      mutations was 32.0%. The average age at diagnosis for\n                      <jats:italic toggle=\"yes\">BRCA1\/2<\/jats:italic>\n                      mutation carriers was notably lower than that observed in non-carriers (43.1 vs 51.7\u00a0years,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .021).\n                      <jats:italic toggle=\"yes\">BRCA1\/2<\/jats:italic>\n                      mutation carriers were also more frequently premenopausal (78.6% vs 43.9%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .025).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      There is a high prevalence of\n                      <jats:italic toggle=\"yes\">BRCA1\/2<\/jats:italic>\n                      mutations among TNBC patients in Vietnam. Women with TNBC in Vietnam should be screened for mutations in\n                      <jats:italic toggle=\"yes\">BRCA1\/2<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10732748261424961","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:32:55Z","timestamp":1770892375000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of\n                    <i>BRCA1<\/i>\n                    and\n                    <i>BRCA2<\/i>\n                    Germline Mutations in Vietnamese Patients With Triple-Negative Breast Cancer"],"prefix":"10.1177","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7693-5282","authenticated-orcid":false,"given":"Tran Trung","family":"Toan","sequence":"first","affiliation":[{"name":"Department of Pathology, Hanoi Medical University"},{"name":"Vietnam National Cancer Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta Van","family":"To","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hanoi Medical University"},{"name":"Vietnam National Cancer Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truong Thi Hoang","family":"Lan","sequence":"additional","affiliation":[{"name":"Vietnam National Cancer Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Van","family":"Thinh","sequence":"additional","affiliation":[{"name":"Vietnam National Cancer Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duong Thi Ngoc","family":"Anh","sequence":"additional","affiliation":[{"name":"Vietnam National Cancer Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bui Thi My","family":"Hanh","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hanoi Medical University"},{"name":"Vietnam National Cancer Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1001389"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4029-y"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.1414"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz012"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00739-2"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0001"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00010"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.5858\/134.6.907"},{"issue":"15","key":"e_1_3_7_10_2","first-page":"2765","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: ASCO\u2013College of American pathologists guideline update","volume":"41","author":"Allison KH","year":"2023","unstructured":"Allison KH, Hammond MEH, Dowsett M, et al. Human epidermal growth factor receptor 2 testing in breast cancer: ASCO\u2013College of American pathologists guideline update. J Clin Oncol. 2023;41(15):2765-2782.","journal-title":"J Clin Oncol"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22981"},{"issue":"5","key":"e_1_3_7_12_2","first-page":"405","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards S","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med Off J Am Coll Med Genet. 2015;17(5):405-424.","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2010.01545.x"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/genes13020268"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2020.21.8.2331"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/1178223420901555"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000455999"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-015-3293-7"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156789"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2021.2258"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-5015-4"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2560"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1294-387"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/378789a0"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.8310"}],"container-title":["Cancer Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10732748261424961","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10732748261424961","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10732748261424961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:24:25Z","timestamp":1777386265000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10732748261424961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":24,"alternative-id":["10.1177\/10732748261424961"],"URL":"https:\/\/doi.org\/10.1177\/10732748261424961","relation":{},"ISSN":["1073-2748","1526-2359"],"issn-type":[{"value":"1073-2748","type":"print"},{"value":"1526-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"article-number":"10732748261424961"}}